Networking at the MESA is an important date on our calendar! Our COO, Simon MacKenzie, will be in Phoenix, Arizona from October 7-9 to catch up on all the latest industry trends, network with peers, and share insights on our tissue therapeutics programs. ➡️ Reach out to Simon to set up a meeting and explore potential collaborations or partnership opportunities. #TissueTherapeutics #MakingCellTherapyImplantable #OnTheMesa #Cellbricks #CGMesa24
Cellbricks
Biotechnologie
Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice
Info
At Cellbricks, we are committed to make a significant impact on the lives of millions of patients dealing with compromised organ function. We achieve this through the innovative production of bioprinted tissue therapeutics, offering humans longer and healthier lives by restoring or supporting organ function. Cellbricks is a biotech company, combining world-leading expertise in synthetic biology and 3D-bioprinting. Leveraging our proprietary biofabrication technology and our tissue engineering proficiency, we are replicating human tissue at scale so researchers and doctors can provide patients with better clinical treatments. Our rapidly growing, multi-disciplinary team consists of biotech enthusiasts, scientists, PhDs, engineers, chemists and entrepreneurs from excellent universities and top companies from all over the world. Our labs and offices are located in Berlin, Europe's start-up capital. For inquiries please contact: Moritz Marschall [email protected]
- Website
-
https://cellbricks.com/
Externer Link zu Cellbricks
- Branche
- Biotechnologie
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berlin
- Art
- Privatunternehmen
- Gegründet
- 2016
- Spezialgebiete
- 3D Bioprinting, Bioink, Biotechnology, Tissue engineering, Breast cancer, Regenerative medicine, LabModels, Recombinant Collagen, TechBio, Oncology, Pharma, Lifesciences, HealthTech, Biologics, Implants, Autologous Tissue Implants, Breast Reconstruction, Stereolithography, Human Tissue und tissue therapeutics
Orte
-
Primär
Müllerstrasse 178
c/o Campus of Bayer AG
Berlin, 13353, DE
Beschäftigte von Cellbricks
Updates
-
Cellbricks is excited to engage in the important "potentials for the future" discussion with Joachim von Arnim as panelist at the renowned #InnoNation Festival organized by BDI - Bundesverband der Deutschen Industrie e.V.! Innovators from business, science, politics, and society will come together for deep-dive discussions on one question: How can Germany become an #InnoNation? Join for our interactive Biotech/Bionic panel, where startups will pitch their transformative projects. These pitches offer a glimpse into cutting-edge developments that could redefine the BioTech industry, thereby the future of health and economic progress. Afterward, we'll discuss key challenges and opportunities, including funding, research support, and regulatory issues for Biotech Startups. We are looking forward to sharing the stage with Simon Fallais, PhD | CDL Therapeutics GmbH, Jens Klein | Insempra, Konstantin Matentzoglu | Polpharma Biologics, Steffen Ganders | German Bionic and moderator, Dr. Thorsten Lambertus | ESMT Berlin DEEP. Supported by: Roland Berger, Boehringer Ingelheim, Bechtle, Dassault Systèmes, DHL, Nokia, OHB SE, QUTAC, Siemens, Die Autobahn GmbH des Bundes, Infineon Technologies, Infosys Consulting, SAP, of Unicorns&Lions, econsense - Forum for Sustainable Development of German Business e.V., #SheTransformsIT, Wissensfabrik. #InnoNation #Cellbricks #Innovation #TissueTherapeutics
-
We are excited to share that we have been honored with the Berlin Economic Award 2024! This award recognizes companies that contribute to Berlin's vibrant entrepreneurial ecosystem - from small and mid-sized businesses to dynamic start-ups driving innovation and change. A huge thank you to Franziska Giffey (Senator for Economic Affairs, Energy and Public Enterprises), Ute Weiland (President, VBKI), and Joachim Spitzley (Initiator, Made in Berlin) for this kind recognition. We also congratulate our fellow award winners, Walter Confiserie and eduBITES - it was a pleasure sharing the stage with you. A special shoutout to Verlag Der Tagesspiegel, Verein Berliner Kaufleute und Industrieller (VBKI), and Made in Berlin for hosting such an encouraging event. We are grateful being part of this amazing community and look forward to what the future holds! 📸 Tagesspiegel Berlinpreis für Wirtschaft 2024 (c) Marie Staggat #BerlinPreisFürWirtschaft #Tagesspiegel #VBKI #Cellbricks #Entrepreneurship #BerlinBusiness #TissueTherapeutics #TissueEngineering #FutureOfMedicine #ThankYou
-
Did you see that #BreakingLab, one of Germany's leading science channels, has visited us recently? The channel presents complex technologies, explaining them in simple words and making breakthrough approaches comprehensible to everyone. They've created an insightful clip about Cellbricks ' technology and our mission of developing life-saving tissue therapeutics for millions of patients worldwide. A big shoutout to Jacob Beautemps and his fabulous and professional team for their great work, and kudos to our team members, Alicia Ruppelt, Tobias Lam and Alexander Leutner, performing in front of the camera! Special thanks to SPRIND - Bundesagentur für Sprunginnovationen, Germany's Federal Agency for Disruptive Innovation, for facilitating this collaboration. 🎥 Watch the documentary here: https://lnkd.in/dprs72MV P.S.: Though audio is German, English subtitles can be selected. #BreakingLab #TissueTherapeutics #ScienceCommunication #SPRIND #Cellbricks #FutureOfMedicine
So druckt dieser 3D-Drucker menschliches Gewebe!
https://www.youtube.com/
-
What does it take to create Europe's next globally leading biotech ecosystem, covering every step from groundbreaking research to successful commercialisation? This was the leading question at this year’s fireside panel discussion at the #DRFZBerlinSymposium2024. Key takeaways from the panel discussion: Strong Consensus: Europe has the huge potential conducting groundbreaking research. Issue: A significant gap exists in translating research from the lab to the clinic, especially due to complex regulatory frameworks. Recommendation: Policymakers must simplify regulatory frameworks and provide clearer guidance to accelerate the path of new therapies to patients. Thanks for this great exchange between our Joachim von Arnim and Eicke Latz (German Rheumatology Research Center) | Stefan Miltenyi (Miltenyi Biotec) | Luke O'Neill (Trinity College Dublin) | Jan-Philipp Kruse (Bayer) | Dr. Thorsten Lambertus (DEEP - ESMT Berlin) as well as moderator Marco Janezic (Blue Ribbon Partners) #TissueTherapeutics #Cellbricks #Charité #MaxPlanckSociety #Ecosystem
-
An exciting week ahead: Cellbricks will be presenting at #TERMIS2024 World Congress in Seattle from June 25-28! Join us for our poster presentation on light-based 3D-bioprinting of vascularised fatty tissue for breast reconstruction. Léa Pourchet, Ph.D., our Senior Tissue Engineer, is eager to connect with you and share our latest advancements in tissue therapeutics. Details: Poster session III, C1, Thursday, June 27 We are looking forward to lively discussions! #TERMIS2024 #RegenerativeMedicine #TissueEngineering #3DBioprinting #Cellbricks #TissueTherapeutics
-
We're hiring – SENIOR LIVER CELL BIOLOGIST! #JoinOurTeam Cellbricks seeks an experienced liver cell biologist to join our Liver Tissue Therapeutics Program. In this role, you'll pioneer methods for scalable liver cell delivery and integrate them into our 3D-bioprinted constructs. Be a part of our mission to revolutionise the lives of millions with compromised organ function by advancing biofabricated tissue therapeutics. Help us enable longer and healthier lives of everyone. Ready to make a difference and for an exciting career step? Apply here: https://lnkd.in/eXNiWcue Let's create something extraordinary together! #JoinOurTeam #NowHiring #Cellbricks #JobOpening #3DBioprinting #Liver #OrganTransplantation #TissueTherapeutics
-
Meet us at BIO International Convention 2024 in San Diego. Our CEO, Alexander Leutner, and COO, Dr. Simon MacKenzie, will attend the conference to talk about our life-saving tissue therapeutics and build collaborations. Who else is going, do you fancy a meeting? Please reach out directly or go through the partnering platform. We are looking forward to seeing you on-site! #BIO2024 #TissueTherapeutics #Cellbricks #Biotech #RegenerativeMedicine #BioInternationalConvention
-
The Dutch Regenerative Medicine Innovation Mission visited Cellbricks to get insights and discuss our tissue therapeutics and light-based 3D-bioprinting platform. Many thanks for the visit and the lively talks. A delegation of representatives from Dutch Regmed organisations travelled to Germany to scout for industry trends and to explore partnership opportunities with companies and institutes as part of the innovation mission of Dutch-German regenerative medicine collaborations. The joint goal of this mission is to bring ground-breaking regenerative medicine treatments to market and enhance patients' quality of life. We are proud to support this mission by producing live-saving tissue therapeutics so that humans can enjoy longer and healthier lives. This innovation mission has been focusing on the Berlin and Munich ecosystems, with stops at the Berlin Institute of Health | chariteberlin | Max Delbrück Center | Cellbricks | Helmholtz Pioneer Campus @ Helmholtz Munich and networking opportunities with Fraunhofer IPA | Fraunhofer TLZ-RT and BioM Biotech Cluster Development GmbH. Big shout to Netherlands Enterprise Agency and Netherlands Innovation Network Germany to develop the mission program in collaboration with RegMed XB and Health~Holland. Thank you for considering us amongst this unique selection of innovative players in the space. Cellbricks is happy to be part of the program and proud of the new connections and friends made: Basic Pharma - Pascal Simoens | BioMiMattInk - Ivo Beeren | UGent - An Van Den Bulcke, Sandra. Van Vlierberghe | Innovation Center for Advanced Therapies (ICAT) - Joost van Duijn, Karel Loerts | Leiden University Medical Center - Hanna Lammertse, PhD | NecstGen - Sophia Kolbe | RegMed XB - Bernard Mulder, Frank Luyten, Lena Wijnen | Scinus Cell Expansion B.V. - Ralf Heijkants | Smart BioMaterials Consortium (SBMC) - Juliette van den Dolder | Eindhoven University of Technology - Harmen de Jongh | Netherlands Heart Institute | Universitair Medisch Centrum Utrecht - Pieter Doevendans We are looking forward to the follow-ups. Let's boost the regenerative medicine space together! #Cellbricks #TissueTherapeutics #NetherlandsEnterpriseAgency #DutchGermanCollaboration #RegenerativeMedicine
-
Three weeks, three events & three stages: many new connections. Our management team was presenting our vision of the future of live-saving tissue therapeutics at various occasions. Many thanks to the hosts for having us. Here are some impressions from the past events. MassBio’s Align Summit, Boston | Dr. Simon MacKenzie, COO Fantastic panel discussions, presentations from seed & series A Biotechs and valuable networking opportunities. Looks like we'll be in town more often. Venture SPRIND, Berlin | Joachim von Arnim, CSO Our supporters at The Federal Agency for Disruptive Innovation (SPRIND - Bundesagentur für Sprunginnovationen) back start-ups developing ground-breaking technologies that can create major impact on society and economy. Over 60 teams from the Deep Tech, Biotech and Life Science sectors presented their solutions. Forever Healthy’s Rejuvenation Summit, Berlin | Alexander Leutner, CEO World’s largest gathering of longevity startups bringing together biotechs, members of the longevity venture capital & investor ecosystem, and researchers – all with the goal of accelerating the development of the rejuvenation biotech industry. #TissueTherapeutics #Cellbricks #AlignSummit24 #VentureSprind #RejuvenationStartupSummit